Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Society of Nephrology. Clinical Journal

• Publication date

  2009-12-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.2215/CJN.02720409PMID 19996005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria.

  2009influential reference
• The effect of joint exposures: examining the presence of interaction.

  2009cited by this paper
• Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

  2009influential reference
• Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.

  2009cited by this paper
• Low serum testosterone increases mortality risk among male dialysis patients.

  2009cited by this paper
• CCR5 deletion protects against inflammation-associated mortality in dialysis patients.

  2009cited by this paper
• IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting.

  2009cited by this paper
• Genetically elevated C-reactive protein and ischemic vascular disease

  2009cited by this paper
• Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.

  2009cited by this paper
• Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients.

  2009influential reference
• Interleukin-6 modulates hepatic and muscle protein synthesis during hemodialysis.

  2008cited by this paper
• Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.

  2008cited by this paper
• Cytokine Dysregulation in Chronic Kidney Disease: How Can We Treat It?

  2008cited by this paper
• Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease.

  2008cited by this paper
• Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.

  2008cited by this paper
• CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients.

  2008cited by this paper
• Vascular access calcification predicts mortality in hemodialysis patients.

  2008cited by this paper
• Telomere attrition is associated with inflammation, low fetuin‐A levels and high mortality in prevalent haemodialysis patients

  2008cited by this paper
• Genetically elevated C-reactive protein and ischemic vascular disease.

  2008cited by this paper
• The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting

  2008cited by this paper
• Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

  2008influential reference
• Low serum fetuin‐A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients

  2008cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008influential reference
• Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases.

  2008cited by this paper
• The association of sudden cardiac death with inflammation and other traditional risk factors.

  2008cited by this paper
• Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.

  2007cited by this paper
• Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2.

  2007influential reference
• Chlamydia pneumoniae accompanied by inflammation is associated with the progression of atherosclerosis in CAPD patients: a prospective study for 3 years.

  2007cited by this paper
• TNF‐related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle‐wasting cytokine

  2007cited by this paper
• Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease

  2007cited by this paper
• C-Reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort.

  2007cited by this paper
• Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women.

  2006cited by this paper
• Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.

  2006influential reference
• Functional variants in the lymphotoxin-alpha gene predict cardiovascular disease in dialysis patients.

  2006cited by this paper
• IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort.

  2006cited by this paper
• Peripheral tissue release of interleukin-6 in patients with chronic kidney diseases: effects of end-stage renal disease and microinflammatory state.

  2006cited by this paper
• The inhibitory effects of interleukin-1 on growth hormone action during catabolic illness.

  2006cited by this paper
• Recombinant human growth hormone improves muscle amino acid uptake and whole-body protein metabolism in chronic hemodialysis patients.

  2005influential reference
• Plasma osteoprotegerin is associated with mortality in hemodialysis patients.

  2005cited by this paper
• Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin.

  2005cited by this paper
• the Effect of

  2004cited by this paper
• Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin

  2004cited by this paper
• Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

  2003cited by this paper
• Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.

  2003cited by this paper
• PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways

  2002cited by this paper
• Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity.

  2002cited by this paper
• Monocyte/Macrophage Regulation of Vascular Calcification In Vitro

  2002cited by this paper
• Differential effects of growth hormone therapy in malnourished hemodialysis patients.

  2001cited by this paper
• Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells.

  2000cited by this paper
• Tumor Necrosis Factor-&agr; Promotes In Vitro Calcification of Vascular Cells via the cAMP Pathway

  2000cited by this paper
• Synergistic effect of interleukin-1 and CD40L on the activation of human renal tubular epithelial cells.

  1999cited by this paper
• Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.

  1999cited by this paper

• Potential host-gut microbiota-metabolite associations in cardiorenal syndrome progression: a multi-omics integrative analysis.

  2026cites this paper
• The Synergistic Risk of Insulin Resistance and Renal Dysfunction in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention

  2025cites this paper
• Preserved ratio impaired spirometry, airflow obstruction, and their trajectories in relationship to chronic kidney disease: a prospective cohort study

  2025cites this paper
• Acute asymptomatic C-reactive protein rise predicts short-term adverse events in peritoneal dialysis patients.

  2025cites this paper
• Proliferation of renal macrophage via MR/CSF1 pathway induced with aldosterone and inhibited by esaxerenone.

  2025cites this paper
• Analysis of risk factors for late arteriovenous fistula failure and patency rates after angioplasty in hemodialysis patients: a retrospective cohort study

  2024cites this paper
• Altered Expression of Intestinal Tight Junctions in Patients with Chronic Kidney Disease: A Pathogenetic Mechanism of Intestinal Hyperpermeability

  2024cites this paper
• Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways

  2024cites this paper
• Influence of autonomic neuropathy, systemic inflammation and other clinical parameters on mortality in dialysis patients

  2024cites this paper
• Kidney Function, Kidney Function Decline, and the Risk of Abdominal Aortic Aneurysm: The Stockholm CREAtinine Measurements (SCREAM) Project.

  2024cites this paper
• The association between new inflammation markers and frequent peritoneal dialysis-associated peritonitis

  2024cites this paper
• Proceedings of a membrane update symposium: advancements, scientific insights, and future trends for dialysis membranes for enhanced clinical outcomes in end stage kidney disease patients

  2024cites this paper
• Oral vitamin C supplementation decreased low-density lipoprotein in adults on hemodialysis: A systematic review and meta-analysis.

  2024cites this paper
• Effect of kidney disease on all-cause and cardiovascular mortality in patients undergoing coronary angiography

  2023cites this paper
• Adipose tissue metabolic changes in chronic kidney disease

  2023cites this paper
• Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?

  2023cites this paper
• Low Free Triiodothyronine as a More Sensitive Predictor of Survival Than Total Testosterone among Dialysis Men

  2023cites this paper
• The relationship between dietary patterns derived from inflammation and cognitive impairment in patients undergoing hemodialysis

  2023cites this paper
• Serum globulin is a novel predictor of mortality in patients undergoing peritoneal dialysis

  2023cites this paper
• Glasgow prognostic score as an outcome predictor for patients initiating hemodialysis

  2023cites this paper
• Resting strain analysis to identify myocardial ischemia in patients with advanced chronic kidney disease

  2023cites this paper
• Interleukin-6 blockade reduces salt-induced cardiac inflammation and fibrosis in subtotal nephrectomized mice.

  2022cites this paper
• The Role of Vitamin K in CKD-MBD

  2022cites this paper
• Inflammation in chronic kidney disease

  2022cites this paper
• Blood Plasma Metabolites in Diabetes-Associated Chronic Kidney Disease: A Focus on Lipid Profiles and Cardiovascular Risk

  2022cites this paper
• Relationship between chronic periodontitis and inflammatory cytokines in patients undergoing maintenance hemodialysis

  2022cites this paper
• Evolving Concepts on Inflammatory Biomarkers and Malnutrition in Chronic Kidney Disease

  2022cites this paper
• Obstructive spirometry pattern and the risk of chronic kidney disease: analysis from the community-based prospective Ansan-Ansung cohort in Korea

  2021cites this paper
• Pro-Inflammatory Effects of Indoxyl Sulfate in Mice: Impairment of Intestinal Homeostasis and Immune Response

  2021cites this paper
• Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

  2021cites this paper
• Valvular Calcific Deposits and Mortality in Peritoneal Dialysis Patients: A Propensity Score-Matched Cohort Analysis

  2021cites this paper
• Chronic kidney disease : a clinical model of premature vascular aging

  2021cites this paper
• Prevalence of unrecognized or “silent” myocardial ischemia in chronic kidney disease patients: Protocol for a systematic review and meta-analysis

  2021cites this paper
• Plasma Protein Carbonyls as Biomarkers of Oxidative Stress in Chronic Kidney Disease, Dialysis, and Transplantation

  2020cites this paper
• Berberine inhibits intestinal epithelial barrier dysfunction in colon caused by peritoneal dialysis fluid by improving cell migration.

  2020cites this paper
• Sarcopenia and inflammation in patients undergoing hemodialysis.

  2020cites this paper
• OP-NDTJ200001 1157..1162

  2020cites this paper
• Pro-Neurotensin depends on renal function and is related to all-cause mortality in chronic kidney disease.

  2020cites this paper
• Relationship between Serum Uric Acid and Mortality Risk in Hemodialysis Patients: A Multicenter Prospective Cohort Study

  2020cites this paper
• Renoprotective Effects of a Novel Receptor-Interacting Protein Kinase 2 Inhibitor, AS3334034, in Uninephrectomized Adriamycin-Induced Chronic Kidney Disease Rats

  2020cites this paper
• Effect of Different Hemodialysis Methods on Microbiota in Uremic Patients

  2020cites this paper
• Systemic inflammation modulates the ability of serum ferritin to predict all-cause and cardiovascular mortality in peritoneal dialysis patients

  2020cites this paper
• Inflammation in Chronic Kidney Disease

  2020cites this paper
• Elevated interleukin 31 serum levels in hemodialysis patients are associated with uremic pruritus.

  2020cites this paper
• Nocturnal haemodialysis is associated with a reduced occurrence of low triiodothyronine serum levels in haemodialysed patients

  2020cites this paper
• Bioinformatics analyses on the immune status of renal transplant patients, a systemic research of renal transplantation

  2020cites this paper
• Aortic Valve Calcium Associates with All-Cause Mortality Independent of Coronary Artery Calcium and Inflammation in Patients with End-Stage Renal Disease

  2020cites this paper
• Gut Microbiome Composition Remains Stable in Individuals with Diabetes-Related Early to Late Stage Chronic Kidney Disease

  2020cites this paper
• Synergistic Effect of Inflammatory Cytokines and Body Adiposity on Insulin Resistance and Endothelial Markers in Patients With Stages 3-5 Chronic Kidney Disease.

  2019cites this paper
• [Middle-molecule uremic toxins: A renewed interest].

  2019cites this paper
• Understanding the gut–kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition

  2019cites this paper
• Serum albumin and mortality in patients with HIV and end-stage renal failure on peritoneal dialysis

  2019cites this paper
• Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy.

  2019cites this paper
• Utilidad del selenio plasmático como biomarcador en enfermedad renal crónica avanzada

  2019cites this paper
• Status of periodontal health in German patients suffering from chronic kidney disease - Data from GCKD study.

  2019cites this paper
• Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease.

  2019cites this paper
• End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal Transplantation

  2019influential citation
• Restless Legs Syndrome in Chronic Kidney Disease: Is Iron or Inflammatory Status To Blame?

  2019cites this paper
• ASSOCIATION BETWEEN CHRONIC KIDNEY DISEASE AND PLASMA HOMOCYSTEINE LEVEL - A HOSPITAL BASED STUDY

  2019cites this paper
• Unique aspects of peripheral artery disease in patients with chronic kidney disease

  2019cites this paper
• Gut Microbiota In Chronic Kidney Disease

  2019cites this paper
• C-reactive protein as a prognostic risk factor for loss of arteriovenous fistula patency in hemodialyzed patients.

  2019cites this paper
• Restless Legs Syndrome in Chronic Kidney Disease: Is Iron or Inflammatory Status To Blame?

  2019cites this paper
• Obesity in Kidney Disease

  2019cites this paper
• Efficacy of Polyunsaturated Fatty Acids on Inflammatory Markers in Patients Undergoing Dialysis: A Systematic Review with Network Meta-Analysis of Randomized Clinical Trials

  2019cites this paper
• The Pathophysiology of Uremia

  2019cites this paper
• Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease

  2019cites this paper
• Circulating Fetuin-A and Risk of All-Cause Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis

  2019cites this paper
• Effects of Synbiotics and Probiotics Supplementation on Serum Levels of Endotoxin, Heat Shock Protein 70 Antibodies and Inflammatory Markers in Hemodialysis Patients: a Randomized Double-Blinded Controlled Trial

  2019influential citation
• Cross-sectional evaluation of the relationship between vitamin D status and supplement use across levels of kidney function in adults

  2019cites this paper
• Modulation of leucocytic angiotensin-converting enzymes expression in patients maintained on high-permeable haemodialysis

  2018cites this paper
• Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies

  2018cites this paper
• Contribution of diminished kidney transplant GFR to increased circulating chemokine ligand 27 level

  2018cites this paper
• Plasma Protein Carbonylation in Haemodialysed Patients: Focus on Diabetes and Gender

  2018cites this paper
• Novel PAradigm to improve Inflammatory burden in end stage Renal disease (rePAIR): study protocol for a randomized controlled trial

  2018cites this paper
• A Population- and Hospital-based Cross-sectional Study of Renal Function in Hidradenitis Suppurativa

  2018cites this paper
• In vitro effect of uremic serum on barrier function and inflammation in human colonocytes

  2018cites this paper
• Serum albumin, inflammation, and nutrition in end‐stage renal disease: C‐reactive protein is needed for optimal assessment

  2018cites this paper
• Inverse J-shaped relation between coronary arterial calcium density and mortality in advanced chronic kidney disease.

  2018cites this paper
• Does inflammation affect outcomes in dialysis patients?

  2018cites this paper
• Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.

  2018cites this paper
• Correlation of Inflammatory markers C-Reactive Protein and Interleukin 6 with Visfatin in Chronic Kidney Disease Patients

  2018cites this paper
• C‐reactive protein variability is associated with vascular access outcome in hemodialysis patients

  2018cites this paper
• The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease

  2018cites this paper
• Extension of longevity and reduction of inflammation is ovarian-dependent, but germ cell-independent in post-reproductive female mice

  2018cites this paper
• OP-NDTJ180357 1..9

  2018cites this paper
• Associations of Physical Activity Energy Expenditure with Nutritional-Inflammatory Markers in Hemodialysis Patients

  2017cites this paper
• Vitamin B-6, Independent of Homocysteine, Is a Significant Factor in Relation to Inflammatory Responses for Chronic Kidney Disease and Hemodialysis Patients

  2017cites this paper
• Title : Inflammation and premature aging in advanced chronic kidney disease 1

  2017cites this paper
• Malnutrition, inflamation and atherosclerosis (MIA syndrome) in patients with end stage renal disease on maintenance hemodialysis (a single centre experience).

  2017cites this paper
• Uremia induces adipose tissue inflammation and muscle mitochondrial dysfunction

  2017cites this paper
• Association between drop-out and inflamation in peritoneal dialysis patients

  2017cites this paper
• Level of inflammatory factors in chronic hemodialysis patients with and without cardiovascular disease

  2017influential citation
• The cross-talk between the kidney and the gut: implications for chronic kidney disease

  2017cites this paper
• Impact of serum and dialysates obtained from chronic hemodialysis patients maintained on high cut‐off membranes on inflammation profile in human THP‐1 monocytes

  2017cites this paper
• AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms.

  2017cites this paper
• Increased risk of chronic kidney disease in patients with rosacea: A nationwide population-based matched cohort study

  2017cites this paper
• Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease—confounding and modifying effects of cardiovascular disease, body composition and inflammation

  2017cites this paper
• Alteration of the gut microbiota in Chinese population with chronic kidney disease

  2017cites this paper
• DNA Damage in End-Stage Renal Disease Patients. Assessment by In Vitro Comet Assay and by Cell-Free DNA Quantification

  2017cites this paper